ANKARA, TURKEY — A strategy that takes advantage of the C in ICD (implantable cardioverter defibrillator), in which the device delivers a shock aimed at restoring sinus rhythm in patients with atrial ...

The drug-shock strategy was more effective for patients experiencing atrial fibrillation for the first time and for patients younger than 70 years, the researchers said. Both the anti-arrhythmia drug ...

A small series provides provocative new data on the safety of performing direct current cardioversion (DCCV) without oral anticoagulation in high-risk patients with a Watchman left atrial appendage ...

Q-I`ve been treated for an abnormal heartbeat for several months, without too much success. My new doctor advises that an electric shock might be used to correct the beat. It`s a frightening thought.

ROME, Italy—ENSURE-AF, the largest randomized trial of anticoagulation for patients undergoing electrical cardioversion for nonvalvular A-fib, has shown that both edoxaban and traditional treatment ...

Medtronic alerted healthcare professionals in Europe to the risk of cardioversion-related damage to the Vanta implantable neurostimulator (INS), model 977006, During cardioversion, healthcare workers ...

A team of Ochsner Health cardiologists recently published an article in the Journal of the American Medical Association (JAMA) Cardiology comparing two treatment strategies for patients with atrial ...

The 204 people randomized to IV procainamide (plus electrical cardioversion if necessary, with up to three shocks) showed a 96% rate of conversion to sinus rhythm that was maintained for at least 30 ...